Search
Recombinant stabilized RSV A prefusion F antigen
go.drugbank.com/drugs/DB18713ApprovedInvestigational[L49555] Abrysvo was approved for the same indications in the EU in August 2023[L49565] and Canada in December 2023.
Nylidrin
go.drugbank.com/drugs/DB06152ApprovedWithdrawnNylidrin is utilized to treat several disorders that may benefit from increased blood flow (for example, certain mental disorders, blood vessel disease due to diabetes, frostbite, night leg cramps, and
Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A SubstratesRimegepant
go.drugbank.com/drugs/DB12457ApprovedInvestigationalmigraine therapy involves abortive treatment with "triptans", such as [sumatriptan], but these medications are contraindicated in patients with pre-existing cerebrovascular and cardiovascular disease due
Categories: P-glycoprotein substrates, Cytochrome P-450 SubstratesViquidacin
go.drugbank.com/drugs/DB19549ExperimentalViquidacin has a monoisotopic molecular weight of 504.16 Da.
Galamustine
go.drugbank.com/drugs/DB21062ExperimentalGalamustine has a monoisotopic molecular weight of 303.06 Da.
Dicirenone
go.drugbank.com/drugs/DB20938ExperimentalDicirenone has a monoisotopic molecular weight of 428.26 Da.
Elmustine
go.drugbank.com/drugs/DB20979ExperimentalElmustine has a monoisotopic molecular weight of 195.04 Da.
Fenaperone
go.drugbank.com/drugs/DB21281ExperimentalFenaperone has a monoisotopic molecular weight of 376.22 Da.
Metrenperone
go.drugbank.com/drugs/DB21312ExperimentalMetrenperone has a monoisotopic molecular weight of 407.2 Da.
Acefylline clofibrol
go.drugbank.com/drugs/DB21353ExperimentalAcefylline clofibrol has a monoisotopic molecular weight of 420.12 Da.